Pragma Bio’s AI-enabled biology-first approach mines an untapped clinically-relevant source of novel small molecules to target the gut-immune axis for diverse clinical applications
Pragma Bio’s AI-enabled biology-first approach mines an untapped clinically-relevant source of novel small molecules to target the gut-immune axis for diverse clinical applications.
Pragma Bio’s AI-enabled biology-first approach mines an untapped clinically-relevant source of novel small molecules to target the gut-immune axis for diverse clinical applications
Pragma Bio’s AI-enabled biology-first approach mines an untapped clinically-relevant source of novel small molecules to target the gut-immune axis for diverse clinical applications.